紅細(xì)胞輸注無(wú)效的原因與安全輸血
發(fā)布時(shí)間:2018-07-29 07:29
【摘要】:目的觀察住院患者輸注紅細(xì)胞的效果,分析影響紅細(xì)胞輸注效果的因素,為臨床科學(xué)、合理輸血提供依據(jù)。方法用回顧性分析的方法對(duì)本院2016年1月-3月486例紅細(xì)胞輸患者的臨床病志、輸血資料以及直接抗球蛋白試驗(yàn)的檢驗(yàn)結(jié)果進(jìn)行統(tǒng)計(jì)和分析。結(jié)果 486例住院患者共輸注紅細(xì)胞1 028次,其中無(wú)效輸血有182次,輸注無(wú)效率為17.7%,既往輸血次數(shù)3次、輸血量16 U紅細(xì)胞輸注無(wú)效率分別為42.7%與39.4%,比輸血次數(shù)3次、輸血量16 U紅細(xì)胞輸注無(wú)效率發(fā)生高;有妊娠史的患者紅細(xì)胞輸注無(wú)效的發(fā)生率為22.19%,比無(wú)妊娠史發(fā)生率高;惡性腫瘤患者與血液病患者紅細(xì)胞輸注無(wú)效的發(fā)生率分別為35.8%與25%,相比其他疾病發(fā)病率高;直接抗球蛋白試驗(yàn)陽(yáng)性(31.6%)比陰性發(fā)生紅細(xì)胞輸注無(wú)效(14.1%)的幾率增高。結(jié)論患者的疾病種類、既往輸血次數(shù)、輸血量、妊娠史及直接抗球蛋白試驗(yàn)的結(jié)果對(duì)輸血效果的影響較為明顯,臨床醫(yī)生應(yīng)嚴(yán)格執(zhí)行科學(xué)合理輸血,盡量減少輸血次數(shù)、重視直接抗球蛋白陽(yáng)性結(jié)果,分析其陽(yáng)性的原因,節(jié)約寶貴的血液資源。
[Abstract]:Objective to observe the effect of red blood cell transfusion in inpatients and analyze the factors that affect the effect of red blood cell transfusion, so as to provide the basis for clinical science and rational blood transfusion. Methods the clinical records, blood transfusion data and the test results of direct antiglobulin test in 486 patients with erythrocyte transfusion from January to March 2016 were analyzed retrospectively. Results A total of 1 028 erythrocytes were infused in 486 inpatients, of which 182 were ineffective blood transfusion, the inefficiency was 17. 7, 3 times of previous blood transfusion, the invalid rate of 16 U red blood cell transfusion was 42. 7% and 39. 4% respectively, which was 3 times than that of blood transfusion. The incidence of ineffective red blood cell transfusion in patients with pregnancy history was 22.19, which was higher than that without pregnancy history. The incidence of ineffective red blood cell transfusion was 35.8% in malignant tumor patients and 25% in hematopathy patients, which was higher than that of other diseases, and the probability of failure of erythrocyte transfusion was higher in direct antiglobulin test (31.6%) than that in negative erythrocyte transfusion (14.1%). Conclusion the types of diseases, the number of previous blood transfusions, the quantity of blood transfusion, the history of pregnancy and the results of direct antiglobulin test have obvious effects on the effect of blood transfusion. The clinicians should strictly carry out scientific and reasonable blood transfusion to reduce the number of blood transfusions as far as possible. Attach importance to direct antiglobulin positive results, analyze the causes of positive, save precious blood resources.
【作者單位】: 遼寧中醫(yī)藥大學(xué)附屬醫(yī)院輸血科;
【分類號(hào)】:R457.1
[Abstract]:Objective to observe the effect of red blood cell transfusion in inpatients and analyze the factors that affect the effect of red blood cell transfusion, so as to provide the basis for clinical science and rational blood transfusion. Methods the clinical records, blood transfusion data and the test results of direct antiglobulin test in 486 patients with erythrocyte transfusion from January to March 2016 were analyzed retrospectively. Results A total of 1 028 erythrocytes were infused in 486 inpatients, of which 182 were ineffective blood transfusion, the inefficiency was 17. 7, 3 times of previous blood transfusion, the invalid rate of 16 U red blood cell transfusion was 42. 7% and 39. 4% respectively, which was 3 times than that of blood transfusion. The incidence of ineffective red blood cell transfusion in patients with pregnancy history was 22.19, which was higher than that without pregnancy history. The incidence of ineffective red blood cell transfusion was 35.8% in malignant tumor patients and 25% in hematopathy patients, which was higher than that of other diseases, and the probability of failure of erythrocyte transfusion was higher in direct antiglobulin test (31.6%) than that in negative erythrocyte transfusion (14.1%). Conclusion the types of diseases, the number of previous blood transfusions, the quantity of blood transfusion, the history of pregnancy and the results of direct antiglobulin test have obvious effects on the effect of blood transfusion. The clinicians should strictly carry out scientific and reasonable blood transfusion to reduce the number of blood transfusions as far as possible. Attach importance to direct antiglobulin positive results, analyze the causes of positive, save precious blood resources.
【作者單位】: 遼寧中醫(yī)藥大學(xué)附屬醫(yī)院輸血科;
【分類號(hào)】:R457.1
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 盧文靜;趙國(guó)勝;;加拿大同種紅細(xì)胞及紅細(xì)胞輸注的社會(huì)單位成本[J];國(guó)外醫(yī)學(xué).輸血及血液學(xué)分冊(cè);2005年02期
2 趙廣超;嚴(yán)京梅;欒建鳳;;紅細(xì)胞輸注無(wú)效的原因及對(duì)策[J];中國(guó)誤診學(xué)雜志;2009年13期
3 劉金菊;;紅細(xì)胞輸注無(wú)效的影響因素及對(duì)策[J];檢驗(yàn)醫(yī)學(xué)與臨床;2012年06期
4 陳靜;姚瑤;郝建英;李永乾;劉立坤;李旭桐;;紅細(xì)胞輸注無(wú)效原因分析[J];河北醫(yī)藥;2012年23期
5 胡開瑞;解讀成份輸血之紅細(xì)胞輸注[J];健康必讀;2003年03期
6 張曉林;紅細(xì)胞輸注的臨床應(yīng)用[J];四川醫(yī)學(xué);2000年05期
7 Hogman CF;Mervman HT;雷宇;;紅細(xì)胞輸注前的質(zhì)量標(biāo)準(zhǔn)[J];國(guó)際輸血及血液學(xué)雜志;2006年04期
8 夏榮;蘭炯采;;重視紅細(xì)胞輸注無(wú)效,提高臨床輸血效果[J];中國(guó)輸血雜志;2008年01期
9 丁琪;孫先玲;蘭炯采;,
本文編號(hào):2151956
本文鏈接:http://sikaile.net/linchuangyixuelunwen/2151956.html
最近更新
教材專著